Cyberounds Logo
September 28, 2020 | LOGIN | REGISTER | HELP | 

email a friend print Bookmark and Share
Cardiac Vagal Neurostimulation for Ventricular Rate Control During Atrial Fibrillation
CME credit is no longer available for this conference.
Youhua Zhang, M.D., Ph.D., and Todor N. Mazgalev, Ph.D.

Dr. Zhang is Project Staff and Dr. Mazgalev is Full Staff, Department of Molecular Cardiology and Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH.

Within the past 12 months, Dr. Zhang and Dr. Mazgalev report no commercial conflicts of interest.

The work described in this Cyberounds® has been supported in part by a grant from the State of Ohio to the Cleveland Clinic Atrial Fibrillation Innovation Center (AFIC), a Wright Center of Innovation.

Albert Einstein College of Medicine, CCME staff and interMDnet staff have nothing to disclose.

Release Date: 08/16/2010
Termination Date: 08/16/2013

Estimated time to complete: 1 hour(s).

Albert Einstein College of Medicine – Montefiore Medical Center designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

In support of improving patient care, this activity has been planned and implemented by Albert Einstein College of Medicine-Montefiore Medical Center and InterMDnet. Albert Einstein College of Medicine – Montefiore Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Learning Objectives
Upon completion of this Cyberounds®, you should be able to:
  • Discuss the current status of efforts to control the atrial fibrillation epidemic
  • Describe the rhythm versus rate control approaches
  • Discuss the intracardiac autonomic nervous system, and specifically the selective vagal control of atrioventricular nodal conduction.
  • Discuss state-of-the-art new technologies utilizing implantable neural electrostimulators to achieve selective modulation of the intracardiac autonomic nervous system in order to control AV conduction and ventricular rate during atrial fibrillation.
  • Assess critically different therapeutic options, including the latest application of implantable neural electrostimulators.

The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.
Please click below to accept the terms of this CME activity